K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

23
K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION

Transcript of K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

Page 1: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

K. BOUKEFATMC 10 KUWAIT28/11 – 1/12/2012

GOVERNMENT MONOPOLYOF

BLOOD TRANSFUSION

Page 2: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

DEFINITION

A MONOPOLY  (FROM GREEK MONOS ΜΌΝΟΣ

(ALONE OR SINGLE) +  POLEIN ΠΩΛΕῖΝ (TO SELL) EXISTS WHEN THERE IS THE ONLY

SUPPLIER OF A PARTICULAR COMMODITY 

Page 3: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

DEFINITION

A GOVERNMENT MONOPOLY (OR PUBLIC MONOPOLY) WHEN A GOVERNMENT AGENCY OR GOVERNMENT CORPORATION IS THE SOLE PROVIDER OF A PARTICULAR GOOD OR SERVICE AND COMPETITION IS PROHIBITED BY LAW.

Page 4: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

DEFINITION

A MONOPOLY IS DISTINGUISHED FROM A MONOPSONY, IN WHICH THERE IS ONLY ONE BUYER OF A PRODUCT OR SERVICE ;

A MONOPOLY MAY ALSO HAVE MONOPSONY CONTROL OF A SECTOR OF A MARKET. (CENTRAL PHARMACY)

Page 5: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

A MONOPOLY IS A SINGLE SELLER

Page 6: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

EXAMPLES OF TUNISIAN GOVERNMENT MONOPOLY IN

THE FIELD OF HEALTH

Page 7: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

TUNISIAN MONOPOLY IN THE FIELD OF HEALTH

1) DRUG IMPORTATION (CENTRAL PHARMACY)2) BLOOD TRANSFUSION (NATIONAL BLOOD TRANSFUSION CENTRE / AND HOSPITAL BB)

Page 8: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

TUNISIAN REGULATION

Page 9: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

LEGAL MONOPOLY OF BLOOD TRANSFUSION IS ESTABLISHED BY LAW . IT ALLOWS YOU TO RESTRICT COMPETITION TO ACHIEVE POLICY OBJECTIVES SUCH AS SAFETY, PLANNING, MANAGING A STRATEGIC AND SOLIDARITY.

Page 10: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

LAW

LAW N° 82-26 MARCH 17TH 1982 CONCERNING, ORGANIZATION OF

SAMPLING HUMAN BLOOD FOR TRANSFUSION

Page 11: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

Art 2)

HUMAN BLOOD CAN BE COLLECTED WITH THE CONSENT, FREE AND CONSCIOUS OF THE PERSON CONCERNED, WITHOUT CONTERPART

=

BLOOD DONOR MUST

BE VNRD

Page 12: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

Art 5

BLOOD COLLECTION CAN BE PERFORMED ONLY IN INSTITUTIONS APPROVED FOR THE PURPOSE (LICENSING)

Page 13: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

•1 NBTC•5 RBTC•1 MBTC•29 BB

Page 14: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

Art 7

THE RECOVERY OF COSTS OF PROCESSING, ANALYSIS AND STORAGE OF BLOOD AND BLOOD

COMPONENTS

TAKES PLACE UNDER CONDITIONS AND ACCORDING TO THE RATES SET BY ORDINANCES, MINISTERS OF FINANCE AND OF PUBLIC HEALTH AND NOT GIVE RISE TO ANY PROFIT

Page 15: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

COST RECOVERY

SINCE 2008 NO CHANGE HAVE BEEN OPERATES IN THE ORDINANCE RELATED TO THE PRICE OF THE BLOOD COMPONENTS

THE PRICE OF SOME PRODUCT ARE UNDERESTIMATED

Page 16: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

ADVANTAGESOF GOVERNMENT

MONOPOLY

Page 17: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

BLOOD TRANSFUSION SERVICES

=CENTRALIZED AND

COORDINATED

Page 18: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

STANDARDIZATION OF BT PRACTICES

ALL THE PROCEDURES STARTING FROM BLOOD DONATION, GOING THROUGH PROCESSING, STORAGE AND DISTRIBUTION. (SOP’S MANUAL)

ALL LAB TECHNICS ARE STANDARDIZED

Page 19: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

PURSHASING

PURCHASING CONSUMABLES IS STANDARDIZED AND CONSOLIDATE D THROUGH CENTRAL PHARMACYBLOOD BAG ( SAME SUPPLIERS)

CONTROLLED BY THE DRUG CONTROL NATIONAL LAB

REAGENTS : IMMUNOHEMATOLOGY/SEROLOGY ( SAME SUPPLIERS ) CONTROLLED BY THE NBTC REFERENCE LAB)

Page 20: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

BLOOD SAFETY REINFORCED

CONDUCTING NATIONAL SURVEY

RELATED TO BLOOD DONATION ( CATEGORIES OF BLOOD DONORS)

TTI MARKERS (PREVALENCE AMONG DONORS)

FOLLOW UP INDICATORS ( NB OF VNRBD, % OF TTI ETC..;)

Page 21: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

NATIONAL POLICY

IMPLEMENTATION OF BLOOD DONATION STRATEGY (since 2008)

IMPLEMENTATION OF A HAEMOVIGILANCE NETWORK (since 2007)

COLLECTION OF SURPLUS OF PLASMA FOR CONTRACT FRACTIONATION

(3 operations since 1999 )

Page 22: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

CONCLUSION

GOVERNMENT MONOPOLY HAS MANY ADVANTAGES CENTRALIZED AND COORDINATED BT

SERVICESIMPLEMENTATION OF NATIONAL

POLICYONLY ONE NATIONAL STRATEGY

Page 23: K. BOUKEF ATMC 10 KUWAIT 28/11 – 1/12/2012 GOVERNMENT MONOPOLY OF BLOOD TRANSFUSION.

CONCLUSION

THE CHAIN OF CONSUMABLES IS UNDER CONTROL

STANDARDIZATION OF BLOOD TRANSFUSION PRACTICES

COST CONTROL AND SINGLE PRICE.